id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0002-0070,FDA,FDA-2015-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Changes of
Sponsorship",Rule,Correction,2016-04-01T04:00:00Z,2016,4,2016-04-01T04:00:00Z,,2016-04-01T14:05:18Z,C1-2016-07135,0,0,0900006481f0947b
FDA-2015-N-0002-0069,FDA,FDA-2015-N-0002,"FONSI for sN 141-361, approved December 7, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:15:00Z,,0,0,0900006481ee9519
FDA-2015-N-0002-0067,FDA,FDA-2015-N-0002,"FOI Summary for sN 141-361, approved December 7, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:37Z,,0,0,0900006481ee9517
FDA-2015-N-0002-0063,FDA,FDA-2015-N-0002,"EA for oN 141-453, approved December 8, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:13:05Z,,0,0,0900006481ee8c48
FDA-2015-N-0002-0062,FDA,FDA-2015-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Changes of
Sponsorship",Rule,Final Rule,2016-03-30T04:00:00Z,2016,3,2016-03-30T04:00:00Z,,2016-03-30T20:48:32Z,2016-07135,0,0,0900006481eea5dc
FDA-2015-N-0002-0066,FDA,FDA-2015-N-0002,"FOI Summary for sN 141-258, approved December 2, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:24Z,,0,0,0900006481ee9516
FDA-2015-N-0002-0068,FDA,FDA-2015-N-0002,"FONSI for  oN 141-453, approved December 8, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:49Z,,0,0,0900006481ee9518
FDA-2015-N-0002-0064,FDA,FDA-2015-N-0002,"EA for sN 141-361, approved December 7, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:13:53Z,,0,0,0900006481ee8c49
FDA-2015-N-0002-0065,FDA,FDA-2015-N-0002,"FOI Summary for oN 141-453, approved December 8, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:12Z,,0,0,0900006481ee9515
FDA-2015-N-0002-0060,FDA,FDA-2015-N-0002,Conditional Approval of a New Animal Drug No Longer in Effect; Masitinib,Rule,Final Rule,2016-01-21T05:00:00Z,2016,1,2016-01-21T05:00:00Z,,2016-01-21T16:13:22Z,2016-01100,0,0,0900006481e24805
FDA-2015-N-0002-0061,FDA,FDA-2015-N-0002,Conditional Approval of a New Animal Drug No Longer In Effect: Masitinib Mesylate Tablets,Notice,Notice of Termination,2016-01-21T05:00:00Z,2016,1,2016-01-21T05:00:00Z,,2016-01-21T16:31:41Z,2016-01104,0,0,0900006481e2489d
FDA-2015-N-0002-0059,FDA,FDA-2015-N-0002,New Animal Drugs for Use in Animal Feeds; Bacitracin Methylenedisalicylate,Rule,Final Rule,2015-12-22T05:00:00Z,2015,12,2015-12-22T05:00:00Z,,2015-12-22T14:25:51Z,2015-32000,0,0,0900006481dc12f6
FDA-2015-N-0002-0057,FDA,FDA-2015-N-0002,"New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of New
Animal Drug Applications; Nitarsone",Rule,Withdrawal,2015-12-18T05:00:00Z,2015,12,2015-12-18T05:00:00Z,,2015-12-18T14:31:28Z,2015-31828,0,0,0900006481db9730
FDA-2015-N-0002-0058,FDA,FDA-2015-N-0002,"New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of New
Animal Drug Applications; Nitarsone",Rule,Final Rule,2015-12-18T05:00:00Z,2015,12,2015-12-18T05:00:00Z,,2015-12-18T14:34:22Z,2015-31827,0,0,0900006481db988a
FDA-2015-N-0002-0050,FDA,FDA-2015-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications;
Withdrawals of Approval of New Animal Drug Applications; Changes of
Sponsorship",Rule,Final Rule,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-09T15:36:21Z,2015-31042,0,0,0900006481d9202e
FDA-2015-N-0002-0051,FDA,FDA-2015-N-0002,"New Animal Drugs; Withdrawal of Approval of New Animal Drug
Applications",Rule,Withdrawal,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-09T15:39:22Z,2015-31040,0,0,0900006481d92512
FDA-2015-N-0002-0053,FDA,FDA-2015-N-0002,"Environmental Assessment Safe-Guard Aquasol for Chicken
(20% Fenbendazole Suspension",Supporting & Related Material,Background Material,2015-12-09T05:00:00Z,2015,12,,,2015-12-09T15:53:03Z,,0,0,0900006481d92b7b
FDA-2015-N-0002-0054,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-449 SAFE-GUARD AquaSol Fenbendazole oral suspension Broiler chickens, replacement chickens intended to become breeding chickens, and breeding chickens",Supporting & Related Material,Freedom of Information Summary,2015-12-09T05:00:00Z,2015,12,,,2015-12-09T15:55:42Z,,0,0,0900006481d92b7d
FDA-2015-N-0002-0056,FDA,FDA-2015-N-0002,"Finding of No Significant Impact (FONSI) for SAFE-GUARD AQUASOL
(fenbendazole oral suspension) in
Chickens",Supporting & Related Material,Background Material,2015-12-09T05:00:00Z,2015,12,,,2015-12-09T16:03:27Z,,0,0,0900006481d92bb3
FDA-2015-N-0002-0052,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-440 CLARO Florfenicol, terbinafine, mometasone furoate otic solution Dog",Supporting & Related Material,Freedom of Information Summary,2015-12-09T05:00:00Z,2015,12,,,2015-12-09T15:47:16Z,,0,0,0900006481d92b7c
FDA-2015-N-0002-0055,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY  NADA 141-442 LUTALYSE HighCon Injection Dinoprost Tromethamine Injection Lactating dairy cows, beef cows, beef heifers, and replacement dairy heifers",Supporting & Related Material,Freedom of Information Summary,2015-12-09T05:00:00Z,2015,12,,,2015-12-09T15:58:53Z,,0,0,0900006481d92bb2
FDA-2015-N-0002-0049,FDA,FDA-2015-N-0002,"FINDING OF NO SIGNIFICANT IMPACT AquAdvantage Salmon In support of an approval of a New Animal Drug Application related to AquAdvantage Salmon, which are triploid, hemizygous, all-female Atlantic salmon (Salmo salar) bearing a single copy of the α-form of the opAFP-GHc2 recombinant DNA construct at the α-locus in the EO-1α lineage",Supporting & Related Material,Background Material,2015-12-07T05:00:00Z,2015,12,,,2015-12-07T16:12:31Z,,0,0,0900006481d8a198
FDA-2015-N-0002-0047,FDA,FDA-2015-N-0002,"AquAdvantage Salmon Environmental Assessment - In support of an approval of a New Animal Drug Application related to AquAdvantage Salmon which are Triploid, Hemizygous, all - female Atlantic salmon (Salmo Salar) bearing a single copy of the a-form of the opAFP-GHc2 recombinant DNA construct at the a-locus in the EO-1a lineage",Supporting & Related Material,Background Material,2015-12-07T05:00:00Z,2015,12,,,2015-12-07T16:04:22Z,,0,0,0900006481d89dac
FDA-2015-N-0002-0048,FDA,FDA-2015-N-0002,Freedom of Information Summary NADA 141-454 opAFP-GHc2 rDNA construct in EO-1a lineage Atlantic Salmon (AquAdvantage Salmon),Supporting & Related Material,Background Material,2015-12-07T05:00:00Z,2015,12,,,2015-12-07T16:12:22Z,,0,0,0900006481d8a194
FDA-2015-N-0002-0046,FDA,FDA-2015-N-0002,"New Animal Drugs in Genetically Engineered Animals; opAFP–GHc2
Recombinant Deoxyribonucleic Acid Construct",Rule,Final Rule,2015-11-24T05:00:00Z,2015,11,2015-11-24T05:00:00Z,,2015-11-24T17:08:38Z,2015-29902,0,0,0900006481d6d2ae
FDA-2015-N-0002-0039,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-438
KAVAULT Avilamycin Type A Medicated Article Swine",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:08Z,,0,0,0900006481cc5629
FDA-2015-N-0002-0041,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY  NADA 141-443
ONSIOR (robenacoxib) injection cats",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:20Z,,0,0,0900006481cc59d1
FDA-2015-N-0002-0031,FDA,FDA-2015-N-0002,"Elanco Animal Health A Division of Eli Lilly and Company
2500 Innovation Way",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:06Z,,0,0,0900006481cc5621
FDA-2015-N-0002-0032,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-553 Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, USP Neomycin and polymyxin B sulfates, and bacitracin zinc Ointment Dogs and cats
For the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:24Z,,0,0,0900006481cc5622
FDA-2015-N-0002-0035,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-583
ACTOGAIN 45 plus RUMENSIN plus TYLOVET 100 plus MGA
Ractopamine Hydrochloride plus Monensin USP plus Tylosin Phosphate plus Melengestrol Acetate Type A Medicated Articles for Use in the Manufacture of Type C Medicated Feeds",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:44Z,,0,0,0900006481cc5625
FDA-2015-N-0002-0037,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-585
ACTOGAIN 45 plus RUMENSIN plus TYLOVET 100 Ractopamine Hydrochloride plus Monensin USP plus Tylosin Phosphate
Type A Medicated Articles for Use in the Manufacture of Type B and Type C Medicated Feeds Cattle Fed in Confinement for Slaughter",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:56Z,,0,0,0900006481cc5627
FDA-2015-N-0002-0045,FDA,FDA-2015-N-0002,"Finding of No Significant Impact (FONSI) for KAVAULT (avilamycin)
Type A Medicated Article For the reduction in incidence and overall severity of diarrhea in the presence of pathogenic Escherichia coli
in Groups of Weaned Pigs Elanco Animal Health Greenfield, IN",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:41Z,,0,0,0900006481cc59d5
FDA-2015-N-0002-0034,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-582
LONCOR 300 Florfenicol Injectable Solution Beef and Non-lactating Dairy Cattle",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:37Z,,0,0,0900006481cc5624
FDA-2015-N-0002-0036,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-584
ENGAIN plus TYLOVET 100 Ractopamine Hydrochloride plus Tylosin Phosphate Type A Medicated Articles for Use in the Manufacture of Type B and Type C Medicated Feeds Finishing Swine",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:50Z,,0,0,0900006481cc5626
FDA-2015-N-0002-0040,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-442
LUTALYSE HighCon Injection Dinoprost tromethamine injection
Lactating dairy cows, beef cows, beef heifers, and replacement dairy heifers",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:13Z,,0,0,0900006481cc59d0
FDA-2015-N-0002-0029,FDA,FDA-2015-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of a New Animal Drug Application; Change of Sponsor; Change of Sponsor’s Address,Rule,Final Rule,2015-10-13T04:00:00Z,2015,10,2015-10-13T04:00:00Z,,2015-10-13T15:04:00Z,2015-25918,0,0,0900006481cc437c
FDA-2015-N-0002-0043,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-509
TILMOVET 90 Tilmicosin Type A medicated article Beef and Non-Lactating Dairy Cattle",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:30Z,,0,0,0900006481cc59d3
FDA-2015-N-0002-0030,FDA,FDA-2015-N-0002,New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of a New Animal Drug Application; Penicillin G Procaine,Rule,Withdrawal,2015-10-13T04:00:00Z,2015,10,2015-10-13T04:00:00Z,,2015-10-13T15:12:02Z,2015-25919,0,0,0900006481cc492e
FDA-2015-N-0002-0033,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-565 Thiabendazole, Dexamethasone, Neomycin Sulfate Solution Dogs and cats",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:48:30Z,,0,0,0900006481cc5623
FDA-2015-N-0002-0038,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-591
NORFENICOL Florfenicol Injectable Solution",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:02Z,,0,0,0900006481cc5628
FDA-2015-N-0002-0042,FDA,FDA-2015-N-0002,FREEDOM OF INFORMATION SUMMARY ANADA 200-495 ENROFLOX 100 Enrofloxacin injectable solution Beef and non-lactating dairy cattle,Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:25Z,,0,0,0900006481cc59d2
FDA-2015-N-0002-0044,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-216 QUEST PLUS Gel
Moxidectin and praziquantel Oral Gel Horses",Supporting & Related Material,Background Material,2015-10-13T04:00:00Z,2015,10,,,2015-10-13T20:49:35Z,,0,0,0900006481cc59d4
FDA-2015-N-0002-0026,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-282 ZILMAX plus RUMENSIN plus MGA
Zilpaterol Hydrochloride; Monensin, USP; and Melengestrol Acetate",Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:12:04Z,,0,0,0900006481c563a8
FDA-2015-N-0002-0020,FDA,FDA-2015-N-0002,New Animal Drugs; Approval of New Animal Drug Applications,Rule,Correction,2015-09-04T04:00:00Z,2015,9,2015-09-04T04:00:00Z,,2015-09-04T14:05:27Z,2015-21905,0,0,0900006481c570fe
FDA-2015-N-0002-0023,FDA,FDA-2015-N-0002,FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA 141-417 CORAXIS Moxidectin Solution Dogs,Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:10:17Z,,0,0,0900006481c563a5
FDA-2015-N-0002-0024,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-188 MARQUIS (ponazuril) Oral Paste
Horses",Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:10:50Z,,0,0,0900006481c563a6
FDA-2015-N-0002-0025,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-262 CERENIA Maropitant Citrate Tablets
Dogs",Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:11:21Z,,0,0,0900006481c563a7
FDA-2015-N-0002-0027,FDA,FDA-2015-N-0002,FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION  NADA 141-284 ZILMAX plus MGA,Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:12:31Z,,0,0,0900006481c563a9
FDA-2015-N-0002-0028,FDA,FDA-2015-N-0002,FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-278 ZILMAX plus RUMENSIN,Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:13:27Z,,0,0,0900006481c563aa
FDA-2015-N-0002-0021,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-497 LOXICOM Meloxicam
Oral Suspension Dogs",Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:08:59Z,,0,0,0900006481c55f0b
FDA-2015-N-0002-0022,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-580 TYLOVET 100 plus SACOX
Tylosin phosphate plus Salinomycin sodium Type A Medicated Articles For Use in the Manufacture of Type C Medicated Feeds Broiler Chickens",Supporting & Related Material,Background Material,2015-09-04T04:00:00Z,2015,9,,,2015-09-04T14:09:50Z,,0,0,0900006481c563a4
FDA-2015-N-0002-0019,FDA,FDA-2015-N-0002,"Determination That BIAXIN XL Oral Tablets Were Not Withdrawn From Sale
for Reasons of Safety or Effectiveness",Notice,Determinations,2015-08-27T04:00:00Z,2015,8,2015-08-27T04:00:00Z,,2015-08-27T14:09:01Z,2015-21236,0,0,0900006481c3d449
FDA-2015-N-0002-0018,FDA,FDA-2015-N-0002,"Determination That ABILIFY (Aripiprazole) Solution Was Not
Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2015-06-23T04:00:00Z,2015,6,2015-06-23T04:00:00Z,,2015-06-23T14:11:08Z,2015-15327,0,0,0900006481b4f384
FDA-2015-N-0002-0011,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-557 Tiletamine-Zolazepam tiletamine HCl and zolazepam HCl Injectable solution
Dogs and cats",Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:07:05Z,,0,0,0900006481b3e437
FDA-2015-N-0002-0016,FDA,FDA-2015-N-0002,FERTAGYL (gonadorelin) Sterile Solution,Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:08:05Z,,0,0,0900006481b3e435
FDA-2015-N-0002-0010,FDA,FDA-2015-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Change of
Sponsor",Rule,Final Rule,2015-06-16T04:00:00Z,2015,6,2015-06-16T04:00:00Z,,2015-06-16T13:51:36Z,2015-14734,0,0,0900006481b3c152
FDA-2015-N-0002-0014,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-238 SPECTRAMAST LC Sterile Suspension
Ceftiofur Intramammary Suspension Cattle (lactating dairy)",Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:07:28Z,,0,0,0900006481b3e43a
FDA-2015-N-0002-0013,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-579 Altrenogest Solution
Altrenogest Oral Solution Swine",Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:07:22Z,,0,0,0900006481b3e439
FDA-2015-N-0002-0012,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-578 Carprofen Flavored Tablets
Carprofen Flavored Tablets Dogs",Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:07:15Z,,0,0,0900006481b3e438
FDA-2015-N-0002-0017,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY ANADA 200-134 FERTAGYL
Gonadorelin Sterile solution Lactating dairy cows",Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:08:20Z,,0,0,0900006481b3e436
FDA-2015-N-0002-0015,FDA,FDA-2015-N-0002,"Finding of No Significant Impact (FONSI) for FERTAGYL (gonadorelin acetate) For use with ESTRUMATE (cloprostenol injection) to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in
Lactating Dairy Cows",Supporting & Related Material,Background Material,2015-06-16T04:00:00Z,2015,6,,,2015-06-16T20:07:39Z,,0,0,0900006481b3e43b
FDA-2015-N-0002-0009,FDA,FDA-2015-N-0002,Withdrawal of Approval of New Animal Drug Application; Chlortetracycline,Notice,Withdrawal,2015-06-04T04:00:00Z,2015,6,2015-06-04T04:00:00Z,,2015-06-04T15:37:26Z,2015-13633,0,0,0900006481b1a331
FDA-2015-N-0002-0003,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY NADA 141-435 ADVANTUS
Imidacloprid Chewable Tablet Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address",Supporting & Related Material,Background Material,2015-04-08T04:00:00Z,2015,4,,,2015-04-08T14:45:09Z,,0,0,0900006481a94545
FDA-2015-N-0002-0004,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY - NADA 141-418 BETAVET Betamethasone sodium phosphate and betamethasone acetate
Injectable Suspension Horses re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address",Supporting & Related Material,Background Material,2015-04-08T04:00:00Z,2015,4,,,2015-04-08T14:50:07Z,,0,0,0900006481a94011
FDA-2015-N-0002-0008,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY - NADA 141-406 NEXGARD
Afoxolaner Chewable Tablet Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address",Supporting & Related Material,Background Material,2015-04-08T04:00:00Z,2015,4,,,2015-04-08T14:50:57Z,,0,0,0900006481a94552
FDA-2015-N-0002-0006,FDA,FDA-2015-N-0002,"Freedom of Information Summary ANADA 200-576 Gentamicin Sulfate Ophthalmic Solution (gentamicin sulfate) Ophthalmic Solution
Dogs and cats re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address",Supporting & Related Material,Background Material,2015-04-08T04:00:00Z,2015,4,,,2015-04-08T14:50:35Z,,0,0,0900006481a9400c
FDA-2015-N-0002-0007,FDA,FDA-2015-N-0002,"FREEDOM OF INFORMATION SUMMARY - NADA 141-280 ZILMAX (zilpaterol hydrochloride) plus RUMENSIN (monensin) plus TYLAN (tylosin phosphate) plus MGA (melengestrol acetate) Type A medicated
articles re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address",Supporting & Related Material,Background Material,2015-04-08T04:00:00Z,2015,4,,,2015-04-08T14:50:45Z,,0,0,0900006481a94551
FDA-2015-N-0002-0002,FDA,FDA-2015-N-0002,"Implantation or Injectable Dosage Form New Animal Drugs; Withdrawal
of Approval of New Animal Drug Application; Fomepizole",Rule,Withdrawal,2015-04-08T04:00:00Z,2015,4,2015-04-08T04:00:00Z,,2015-04-08T14:01:00Z,2015-08024,0,0,0900006481a9424e
FDA-2015-N-0002-0001,FDA,FDA-2015-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address,Rule,Final Rule,2015-04-08T04:00:00Z,2015,4,2015-04-08T04:00:00Z,,2015-04-08T13:56:23Z,2015-08025,0,0,0900006481a9424b
FDA-2015-N-0002-0005,FDA,FDA-2015-N-0002,Freedom of Information Summary - ANADA 200-527 Enrofloxacin Antibacterial Injectable Solution re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor’s Name; Change of Sponsor’s Address,Supporting & Related Material,Background Material,2015-04-08T04:00:00Z,2015,4,,,2015-04-08T14:50:22Z,,0,0,0900006481a93fcb